ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells (Q28236488)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 14 September 2006)
edit
Language Label Description Also known as
English
ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells
scientific article (publication date: 14 September 2006)

    Statements

    ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells (English)
    0 references
    D Noda
    0 references
    S Itoh
    0 references
    Y Watanabe
    0 references
    M Inamitsu
    0 references
    S Dennler
    0 references
    F Itoh
    0 references
    S Koike
    0 references
    D Danielpour
    0 references
    P ten Dijke
    0 references
    M Kato
    0 references
    14 September 2006
    0 references
    0 references
    25
    0 references
    5591-600
    0 references
    41
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit